Burden of Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Adults: Significant Adverse Outcomes and Costs beyond Direct Treatment.

Kononoff J, Anttila VJ, Klemets P, Kalaoja M, Pölkki M, Korhonen MJ

Open source

DOI
10.1007/s40121-026-01357-w
Published
2026 Jul
Container
Infectious diseases and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40121-026-01357-w,
  title = {Burden of Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Adults: Significant Adverse Outcomes and Costs beyond Direct Treatment.},
  author = {Kononoff J and Anttila VJ and Klemets P and Kalaoja M and Pölkki M and Korhonen MJ},
  year = {2026},
  journal = {Infectious diseases and therapy},
  doi = {10.1007/s40121-026-01357-w},
  url = {https://doi.org/10.1007/s40121-026-01357-w}
}

RIS

TY  - JOUR
TI  - Burden of Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Adults: Significant Adverse Outcomes and Costs beyond Direct Treatment.
AU  - Kononoff J
AU  - Anttila VJ
AU  - Klemets P
AU  - Kalaoja M
AU  - Pölkki M
AU  - Korhonen MJ
PY  - 2026
JO  - Infectious diseases and therapy
DO  - 10.1007/s40121-026-01357-w
UR  - https://doi.org/10.1007/s40121-026-01357-w
ER  - 

APA

J, K., VJ, A., P, K., M, K., M, P., & MJ, K. (2026). Burden of Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Adults: Significant Adverse Outcomes and Costs beyond Direct Treatment.. Infectious diseases and therapy. https://doi.org/10.1007/s40121-026-01357-w

Source records